These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21509907)

  • 1. Concise review: Emerging concepts in clinical targeting of cancer stem cells.
    Rasheed ZA; Kowalski J; Smith BD; Matsui W
    Stem Cells; 2011 Jun; 29(6):883-7. PubMed ID: 21509907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and targeting of pancreatic cancer stem cells.
    Penchev VR; Rasheed ZA; Maitra A; Matsui W
    Clin Cancer Res; 2012 Aug; 18(16):4277-84. PubMed ID: 22896694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma.
    Rasheed ZA; Matsui W
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):15-8. PubMed ID: 22320910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CSC-related miRNAs for cancer therapy by natural agents.
    Bao B; Li Y; Ahmad A; Azmi AS; Bao G; Ali S; Banerjee S; Kong D; Sarkar FH
    Curr Drug Targets; 2012 Dec; 13(14):1858-68. PubMed ID: 23140295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
    Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
    Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.
    Bao B; Ahmad A; Azmi AS; Ali S; Sarkar FH
    Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.25. PubMed ID: 23744710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: relevance to SCT.
    Lin T; Jones RJ; Matsui W
    Bone Marrow Transplant; 2009 Apr; 43(7):517-23. PubMed ID: 19234507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cancer Stem Cells: Promises and Challenges.
    Kuhlmann JD; Hein L; Kurth I; Wimberger P; Dubrovska A
    Anticancer Agents Med Chem; 2016; 16(1):38-58. PubMed ID: 26179271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.